The present invention includes compounds useful as modulators of TRPM8, such as compounds of Formulae (Ia), (Ib) and (Ic), and the subgenus and species thereof; personal products containing those compounds; and the use of those compounds and the personal products, particularly the use of increasing or inducing chemesthetic sensations, such as cooling or cold sensations.
An efficient enantioselective hydrogenation of sterically hindered cyclic imines catalyzed by the Ir-tBu-ax-Josiphos complex has been described, producing a series of useful chiral bulky tetrahydroisoquinoline analogs in high isolated yields (85–96%) with good to excellent enantioselectivities (74–99% ee). This transformation provided highly straightforward access to the useful derivatives of tetrahydroisoquinolines
[EN] ORALLY-BIOAVAILABLE NUCLEOSIDE ANALOGS<br/>[FR] ANALOGUES DE NUCLÉOSIDES À BIODISPONIBILITÉ ORALE
申请人:VENATORX PHARMACEUTICALS INC
公开号:WO2022265964A1
公开(公告)日:2022-12-22
Described herein are orally-bioavailable nucleoside analogs and pharmaceutical compositions comprising said compounds. The subject compounds and compositions are useful for the treatment of coronavirus infections, including SARS-CoV-2 infection.
The present invention includes compounds useful as modulators of TRPM8, such as compounds of Formulae (Ia), (Ib) and (Ic), and the subgenus and species thereof; personal products containing those compounds; and the use of those compounds and the personal products, particularly the use of increasing or inducing chemesthetic sensations, such as cooling or cold sensations.